T1	Outcomes 407 488	KRAS mutation status, clinicopathologic features, and disease-free survival (DFS)
T2	Outcomes 819 832	KRAS mutation
T3	Outcomes 1061 1074	tumor samples
T4	Outcomes 1491 1512	KRAS mutation status,
T5	Outcomes 1558 1561	DFS